The global pharmaceutical market continuously seeks robust supply chains for essential drug intermediates. For the antifungal agent Voriconazole, 1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone (CAS 86404-63-9) is a cornerstone intermediate, critical for its synthesis. Understanding the manufacturing processes, quality requirements, and sourcing strategies for such compounds is vital for pharmaceutical manufacturers and researchers alike. As a specialized manufacturer and supplier from China, we offer expertise and high-quality products to meet these demands.

The production of 1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone involves precise chemical synthesis to achieve the required purity levels, typically with an assay of ≥98.0% on a dry basis. Its physical characteristics, such as a light yellow crystalline powder, and controlled parameters like loss on drying (≤1.0%) and melting point (103-108°C), are crucial for its successful application in the Voriconazole synthesis pathway. Pharmaceutical R&D scientists rely on these consistent specifications to ensure reproducible results in their development programs.

For companies looking to buy this intermediate, selecting a supplier with strong manufacturing capabilities and a commitment to quality assurance is paramount. We, as a manufacturer in China, offer a reliable source of this vital chemical, coupled with competitive pricing for bulk orders. Our focus on efficient production and a well-managed supply chain ensures that you receive a consistent supply of high-purity 1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone to support your manufacturing needs.

We invite you to consider our offerings for 1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone. By partnering with us, you gain access to a dependable supplier backed by rigorous quality standards and dedicated customer support. Requesting a quote is the first step towards securing a stable supply of this essential intermediate for your Voriconazole production, ensuring quality and efficiency in your pharmaceutical manufacturing operations.